Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prefrontal circuits for cognitive flexibility in extradimensional set-shifting in humans
2019-004018-33Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of citalopram and escitalopram in major depressive disorder (MDD), sponsored by Medical University of Vienna. Primary endpoints: brain structure, brain activity and connectivity and 1 more. Started Jun 2020; status: completed.
02
Drugs
citalopramescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2019-004018-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004018-33.